Auricular fibrillation; A-fib; Afib
Atrial fibrillation or flutter is a common type of abnormal heartbeat. The heart rhythm is fast and most often irregular.
When working well, the 4 chambers of the heart contract (squeeze) in an organized way.
Electrical signals direct your heart to pump the right amount of blood for your body's needs. The signals begin in an area called the sinoatrial node (also called the sinus node or SA node).
In atrial fibrillation, the electrical impulse of the heart is not regular. This is because the sinoatrial node no longer controls the heart rhythm.
In atrial flutter, the ventricles (lower heart chambers) may beat very rapidly, but in a regular pattern.
These problems can affect both men and women. They become more common with increasing age.
Common causes of atrial fibrillation include:
You may not be aware that your heart is not beating in a normal pattern.
Symptoms may start or stop suddenly. This is because atrial fibrillation may stop or start on its own.
Symptoms may include:
The health care provider may hear a fast heartbeat while listening to your heart with a stethoscope. Your pulse may feel fast, uneven, or both.
The normal heart rate is 60 to 100 beats per minute. In atrial fibrillation or flutter, the heart rate may be 100 to 175 beats per minute. Blood pressure may be normal or low.
An ECG (a test that records the electrical activity of the heart) may show atrial fibrillation or atrial flutter.
If your abnormal heart rhythm comes and goes, you may need to wear a special monitor to diagnose the problem. The monitor records the heart's rhythms over a period of time.
Tests to find heart disease may include:
Cardioversion treatment is used to get the heart back into a normal rhythm right away. There are two options for treatment:
These treatments may be done as emergency methods, or planned ahead of time.
Daily medicines taken by mouth are used to:
A procedure called radiofrequency ablation can be used to scar areas in your heart where the heart rhythm problems are triggered. This can prevent the abnormal electrical signals that cause atrial fibrillation or flutter from moving through your heart. You may need a heart pacemaker after this procedure. All people with atrial fibrillation will need to learn how to manage this condition at home.
People with atrial fibrillation will most often need to take blood thinner medicines. These drugs tare used to reduce the risk of developing a blood clot that travels in the body (and that can cause a stroke, for example). The irregular heart rhythm that occurs with atrial fibrillation makes blood clots more likely to form.
Blood thinner medicines include heparin, warfarin (Coumadin), apixaban (Eliquis), rivaroxaban (Xarelto), edoxaban (Savaysa) and dabigatran (Pradaxa). Antiplatelet drugs such as aspirin or clopidogrel may also be prescribed. However, blood thinners increase the chance of bleeding, so not everyone can use them.
Another stroke prevention option for people who cannot safely take these medicines is the Watchman Device, which has recently been approved by the FDA. This is a small basket-shaped implant that is placed inside the heart to block off the area of the heart where most of the clots form. This limits clots form forming.
Your provider will consider your age and other medical problems when deciding which stroke prevention methods are best for you.
Treatment can often control this disorder. Many people with atrial fibrillation do very well with treatment.
Atrial fibrillation tends to return and get worse. It may come back in some people, even with treatment.
Clots that break off and travel to the brain can cause a stroke.
Call your provider if you have symptoms of atrial fibrillation or flutter.
Talk to your provider about steps to treat conditions that cause atrial fibrillation and flutter. Avoid binge drinking.
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140(6)e285. PMID: 30686041 pubmed.ncbi.nlm.nih.gov/30686041.
Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest. 2018;154(5):1121-1201. PMID: 30144419 pubmed.ncbi.nlm.nih.gov/30144419/.
Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832. PMID: 25355838 pubmed.ncbi.nlm.nih.gov/25355838.
Morady F, Zipes DP. Atrial fibrillation: clinical features, mechanisms, and management. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 38.
Zimetbaum P. Supraventricular cardiac arrhythmias. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 58.BACK TO TOP
Review Date: 1/27/2020
Reviewed By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Internal review and update on 06/03/2021 by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2021 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.